XML 63 R49.htm IDEA: XBRL DOCUMENT v3.22.0.1
Financial Instruments - Fair Values on Recurring Basis (Details) - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Equity Securities, FV-NI, Gain (Loss)      
Equity securities, unrealized gain (loss) $ 11,600 $ 448 $ 4
Rivian      
Equity Securities, FV-NI, Gain (Loss)      
Equity investment, fair value 15,600    
Recurring      
Schedule of Investments [Line Items]      
Cash 10,942 10,063  
Cost or Amortized Cost      
Cash, cash equivalents and short-term investments 79,012 83,624  
Gross Unrealized Gains      
Cash equivalents and marketable securities 93 377  
Gross Unrealized Losses      
Cash equivalents and marketable securities (182) (5)  
Total Estimated Fair Value      
Cash, cash equivalents and short-term investments 96,309 84,653  
Less: Restricted cash, cash equivalents, and marketable securities (260) (257)  
Total cash, cash equivalents, and marketable securities 96,049 84,396  
Recurring | Level 1 securities      
Total Estimated Fair Value      
Equity securities 1,646 617  
Recurring | Level 1 securities | Money market funds      
Schedule of Investments [Line Items]      
Money market funds 20,312 27,430  
Recurring | Level 1 securities | Money market funds | Money market funds      
Schedule of Investments [Line Items]      
Money market funds 20,312    
Recurring | Level 2 securities      
Total Estimated Fair Value      
Equity securities 15,740 40  
Recurring | Level 2 securities | Foreign government and agency securities      
Cost or Amortized Cost      
Cash equivalents and marketable securities 181 5,130  
Gross Unrealized Gains      
Cash equivalents and marketable securities 0 1  
Gross Unrealized Losses      
Cash equivalents and marketable securities 0 0  
Total Estimated Fair Value      
Cash equivalents and marketable securities 181 5,131  
Recurring | Level 2 securities | U.S. government and agency securities      
Cost or Amortized Cost      
Cash equivalents and marketable securities 4,316 7,410  
Gross Unrealized Gains      
Cash equivalents and marketable securities 9 30  
Gross Unrealized Losses      
Cash equivalents and marketable securities (25) (1)  
Total Estimated Fair Value      
Cash equivalents and marketable securities 4,300 7,439  
Recurring | Level 2 securities | Corporate debt securities      
Cost or Amortized Cost      
Cash equivalents and marketable securities 35,810 29,684  
Gross Unrealized Gains      
Cash equivalents and marketable securities 75 305  
Gross Unrealized Losses      
Cash equivalents and marketable securities (121) (1)  
Total Estimated Fair Value      
Cash equivalents and marketable securities 35,764 29,988  
Recurring | Level 2 securities | Asset-backed securities      
Cost or Amortized Cost      
Cash equivalents and marketable securities 6,763 3,206  
Gross Unrealized Gains      
Cash equivalents and marketable securities 7 32  
Gross Unrealized Losses      
Cash equivalents and marketable securities (32) (3)  
Total Estimated Fair Value      
Cash equivalents and marketable securities 6,738 3,235  
Recurring | Level 2 securities | Other fixed income securities      
Cost or Amortized Cost      
Cash equivalents and marketable securities 688 701  
Gross Unrealized Gains      
Cash equivalents and marketable securities 2 9  
Gross Unrealized Losses      
Cash equivalents and marketable securities (4) 0  
Total Estimated Fair Value      
Cash equivalents and marketable securities $ 686 $ 710